Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. (Q44586222)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Nicola Lautenschlager

object named as

Nicola Lautenschlager

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Kevin Taddei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Elizabeth Scarr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Elizabeth A Thomas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Clive Harper

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Catriona McClean

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Samuel E Gandy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Colin Masters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

616-622

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13129656%20AND%20SRC:MED&resulttype=core&format=json

Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E genotype and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E genotype in Spanish schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E alleles in childhood-onset schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E type ϵ4 allele frequency is increased in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Association study of apolipoprotein E epsilon4 with clinical phenotype and clozapine response in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E genotype and psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E-epsilon 4 frequency in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

The rat, a useful animal model for pharmacological studies on apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E ε4 and clinical phenotype in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E4 in schizophrenia: A study of one hundred sixteen cases with concomitant neuropathological examination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E ɛ4 and clinical phenotype in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E regulatory region genotype in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

No implication of apolipoprotein E polymorphism in Italian schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E-varepsilon4 frequency in deficit schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1

Apolipoprotein E genotyping by one-stage PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900075-1